Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 13
2004 10
2005 9
2006 15
2007 12
2008 12
2009 14
2010 7
2011 16
2012 19
2013 10
2014 15
2015 11
2016 6
2017 9
2018 14
2019 11
2020 5
2021 7
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
Case report: Cardiac intimal sarcoma in a young child.
Verbeek S, Sciot R, Debiec-Rychter M, Labarque V, Meyns B, Cools B. Verbeek S, et al. Among authors: debiec rychter m. Front Pediatr. 2023 Sep 25;11:1238847. doi: 10.3389/fped.2023.1238847. eCollection 2023. Front Pediatr. 2023. PMID: 37818167 Free PMC article.
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ, Modave E, Boeckx B, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Debiec-Rychter M, Sciot R, Lambrechts D, Wozniak A, Schöffski P. Lee CJ, et al. Among authors: debiec rychter m. Int J Mol Sci. 2022 May 19;23(10):5689. doi: 10.3390/ijms23105689. Int J Mol Sci. 2022. PMID: 35628499 Free PMC article.
Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial.
Lee CJ, Modave E, Boeckx B, Stacchiotti S, Rutkowski P, Blay JY, Debiec-Rychter M, Sciot R, Lambrechts D, Wozniak A, Schöffski P. Lee CJ, et al. Among authors: debiec rychter m. Cancers (Basel). 2021 Dec 1;13(23):6057. doi: 10.3390/cancers13236057. Cancers (Basel). 2021. PMID: 34885165 Free PMC article.
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.
Lee CJ, Schöffski P, Modave E, van Wezel T, Boeckx B, Sufliarsky J, Gelderblom H, Blay JY, Debiec-Rychter M, Sciot R, Bovée JVMG, Lambrechts D, Wozniak A. Lee CJ, et al. Among authors: debiec rychter m. Clin Cancer Res. 2021 Dec 15;27(24):6737-6748. doi: 10.1158/1078-0432.CCR-21-1165. Epub 2021 Sep 22. Clin Cancer Res. 2021. PMID: 34551905
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Schöffski P, Kubickova M, Wozniak A, Blay JY, Strauss SJ, Stacchiotti S, Switaj T, Bücklein V, Leahy MG, Italiano A, Isambert N, Debiec-Rychter M, Sciot R, Lee CJ, Speetjens FM, Nzokirantevye A, Neven A, Kasper B. Schöffski P, et al. Among authors: debiec rychter m. Eur J Cancer. 2021 Oct;156:12-23. doi: 10.1016/j.ejca.2021.07.016. Epub 2021 Aug 13. Eur J Cancer. 2021. PMID: 34392187 Free article. Clinical Trial.
Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 Patients.
Kyriazoglou A, Timmermans I, De Cock L, Laenen A, Dumez H, Sinnaeve F, Wafa H, Hompes D, Van Raemdonck D, De Leyn P, Sciot R, Hauben E, Debiec-Rychter M, Vandenbempt I, Schöffski P. Kyriazoglou A, et al. Among authors: debiec rychter m. Oncol Res Treat. 2021;44(5):232-241. doi: 10.1159/000515112. Epub 2021 Mar 23. Oncol Res Treat. 2021. PMID: 33756486 Free article.
211 results